tiprankstipranks
Advertisement
Advertisement

HK:2256 Stock Latest News

Abbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility
Company AnnouncementsAbbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility
1d ago
2256
Abbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development
PremiumCompany Announcements
Abbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development
23d ago
2256
Abbisko Moves to Modernise Governance With Digital-Ready Articles Update
PremiumCompany Announcements
Abbisko Moves to Modernise Governance With Digital-Ready Articles Update
23d ago
2256
Abbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate
PremiumCompany Announcements
Abbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate
23d ago
2256
Abbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR
PremiumCompany Announcements
Abbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR
29d ago
2256
Abbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push
PremiumCompany AnnouncementsAbbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push
1M ago
2256
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
Premium
Company Announcements
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
1M ago
2256
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
Premium
Company Announcements
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
2M ago
2256
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
PremiumCompany Announcements
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
2M ago
2256
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
PremiumCompany Announcements
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
2M ago
2256
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
PremiumCompany Announcements
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
2M ago
2256
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
PremiumCompany Announcements
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
2M ago
2256
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
PremiumCompany AnnouncementsAbbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
2M ago
2256
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
Premium
Company Announcements
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
3M ago
2256
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
Premium
Company Announcements
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
3M ago
2256
Abbisko Wins First China Drug Approval, Reshuffles Secretaries as Merck Deepens Tie-Up
PremiumCompany Announcements
Abbisko Wins First China Drug Approval, Reshuffles Secretaries as Merck Deepens Tie-Up
3M ago
2256
Abbisko Cayman Sets March Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
Abbisko Cayman Sets March Board Meeting to Approve 2025 Results and Consider Dividend
3M ago
2256
Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial
PremiumCompany Announcements
Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial
3M ago
2256
Abbisko Wins FDA Fast Track for Precision Liver Cancer Drug Irpagratinib
PremiumCompany Announcements
Abbisko Wins FDA Fast Track for Precision Liver Cancer Drug Irpagratinib
3M ago
2256
Abbisko’s TGCT Drug Pimicotinib Wins FDA NDA Acceptance After Strong Phase III Data
PremiumCompany AnnouncementsAbbisko’s TGCT Drug Pimicotinib Wins FDA NDA Acceptance After Strong Phase III Data
4M ago
2256
Abbisko Wins NMPA IND Clearance for Novel KRAS G12D Cancer Drug ABSK141
Premium
Company Announcements
Abbisko Wins NMPA IND Clearance for Novel KRAS G12D Cancer Drug ABSK141
5M ago
2256
Abbisko Wins First Global Approval for TGCT Drug Pimicotinib in China
Premium
Company Announcements
Abbisko Wins First Global Approval for TGCT Drug Pimicotinib in China
5M ago
2256

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >